81 related articles for article (PubMed ID: 15904429)
1. In view of an optimal gut antifungal therapeutic strategy: an in vitro susceptibility and toxicity study testing a novel phyto-compound.
Metugriachuk Y; Kuroi O; Pavasuthipaisit K; Tsuchiya J; Minelli E; Okura R; Fesce E; Marotta F
Chin J Dig Dis; 2005; 6(2):98-103. PubMed ID: 15904429
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde.
Lee SH; Lee JR; Lunde CS; Kubo I
Planta Med; 1999 Apr; 65(3):204-8. PubMed ID: 10232062
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel phyto-compound on mucosal candidiasis: further evidence from an ex vivo study.
Nakajima J; Papaah P; Yoshizawa M; Marotta F; Nakajima T; Mihara S; Minelli E
J Dig Dis; 2007 Feb; 8(1):48-51. PubMed ID: 17261135
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel phosphoramidate derivatives of coumarin as chitin synthase inhibitors and antifungal agents.
Ji Q; Ge Z; Ge Z; Chen K; Wu H; Liu X; Huang Y; Yuan L; Yang X; Liao F
Eur J Med Chem; 2016 Jan; 108():166-176. PubMed ID: 26647304
[TBL] [Abstract][Full Text] [Related]
5. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi.
Wiederhold NP; Patterson TF; Srinivasan A; Chaturvedi AK; Fothergill AW; Wormley FL; Ramasubramanian AK; Lopez-Ribot JL
Virulence; 2017 Feb; 8(2):138-142. PubMed ID: 27268469
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of 3-acetylbenzamide produced by actinomycete WA23-4-4 from the intestinal tract of Periplaneta americana.
Fang X; Shen J; Wang J; Chen ZL; Lin PB; Chen ZY; Liu LY; Zeng HX; Jin XB
J Microbiol; 2018 Jul; 56(7):516-523. PubMed ID: 29956124
[TBL] [Abstract][Full Text] [Related]
9. Preventive strategy for Candida gut translocation during ischemia-reperfusion injury supervening on protein-calorie malnutrition.
Marotta F; Barreto R; Kawakita S; Minelli E; Pavasuthipaisit K; Lorenzetti A; Nishiwaki M; Gelosa F; Fesce E; Okura R
Chin J Dig Dis; 2006; 7(1):33-8. PubMed ID: 16412035
[TBL] [Abstract][Full Text] [Related]
10. Potent in vitro antifungal activities of naturally occurring acetylenic acids.
Li XC; Jacob MR; Khan SI; Ashfaq MK; Babu KS; Agarwal AK; Elsohly HN; Manly SP; Clark AM
Antimicrob Agents Chemother; 2008 Jul; 52(7):2442-8. PubMed ID: 18458131
[TBL] [Abstract][Full Text] [Related]
11. The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.
Myc A; Vanhecke T; Landers JJ; Hamouda T; Baker JR
Mycopathologia; 2002; 155(4):195-201. PubMed ID: 12650595
[TBL] [Abstract][Full Text] [Related]
12. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification and in vitro antifungal activity of acidic mammalian chitinase against Candida albicans, Aspergillus fumigatus and Trichophyton rubrum strains.
Chen L; Shen Z; Wu J
Clin Exp Dermatol; 2009 Jan; 34(1):55-60. PubMed ID: 19076793
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species.
Chen M; Zhai L; Arendrup MC
Med Mycol; 2015 Feb; 53(2):194-8. PubMed ID: 25605775
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
16. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
Jessup C; Reyes G; Fothergill A; McCarthy D; Rinaldi M; Messer S; Pfaller M; Ghannoum M
J Chemother; 2000 Feb; 12(1):22-9. PubMed ID: 10768512
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of amphotericin-B pimaricin and gentian violet on ocular fungi.
Lavingia B; Dave S
Indian J Ophthalmol; 1986; 34():73-7. PubMed ID: 3155339
[No Abstract] [Full Text] [Related]
18. FR227244, a novel antifungal antibiotic from Myrothecium cinctum No. 002. II. Biological properties and mode of action.
Kobayashi M; Sato I; Abe F; Nitta K; Hashimoto M; Fujie A; Hino M; Hori Y
J Antibiot (Tokyo); 2004 Dec; 57(12):788-96. PubMed ID: 15745113
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of silver nanoparticles obtained by green synthesis.
Mallmann EJ; Cunha FA; Castro BN; Maciel AM; Menezes EA; Fechine PB
Rev Inst Med Trop Sao Paulo; 2015; 57(2):165-7. PubMed ID: 25923897
[TBL] [Abstract][Full Text] [Related]
20. Extracts of three Laserpitium L. species and their principal components laserpitine and sesquiterpene lactones inhibit microbial growth and biofilm formation by oral Candida isolates.
Popović V; Stojković D; Nikolić M; Heyerick A; Petrović S; Soković M; Niketić M
Food Funct; 2015 Apr; 6(4):1205-11. PubMed ID: 25720441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
